Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 5 of 5 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine (D00095) | 3件: Bupivacaine Bupivacaine,Clonidine, Epinephrine | 3件: Epinephrine
Epinephrine
(D00095),Clonidine , Bupivacaine 💬 1. Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine
| 14件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 1. Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 1件: 70 70 💬1. Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine
| ||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Bupivacaine/epinephrine/dexamethasone (D00095) | 3件: Bupivacaine Bupivacaine,Dexamethasone, Epinephrine | 3件: Epinephrine
Epinephrine
(D00095),Dexamethasone , Bupivacaine 💬 2. Bupivacaine/epinephrine/dexamethasone
| 15件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A ... 2. Bupivacaine/epinephrine/dexamethasone
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 1件: 96 96 💬2. Bupivacaine/epinephrine/dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Epinephrine (D00095) | 1件: Epinephrine Epinephrine | 1件: Epinephrine
Epinephrine
(D00095) 💬3. Epinephrine
| 9件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 3件: 46 46, 70, 96 💬
| ||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Lap TAP Bupivacaine/Epinephrine (D00095) | 2件: Bupivacaine Bupivacaine,Epinephrine | 2件: Epinephrine
Epinephrine
(D00095),Bupivacaine 💬 4. Lap TAP Bupivacaine/Epinephrine
| 14件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 4. Lap TAP Bupivacaine/Epinephrine
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 1件: 96 96 💬4. Lap TAP Bupivacaine/Epinephrine
| ||||||||||||||||||||||||||||||||||||||||||||||
| 5 | US TAP Bupivacaine/Epinephrine (D00095) | 2件: Bupivacaine Bupivacaine,Epinephrine | 2件: Epinephrine
Epinephrine
(D00095),Bupivacaine 💬 5. US TAP Bupivacaine/Epinephrine
| 14件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 5. US TAP Bupivacaine/Epinephrine
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 1件: 96 96 💬5. US TAP Bupivacaine/Epinephrine
|